Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
RETRACTED: Richards et al. Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC). Int. J. Mol. Sci. 2023, 24, 10545.
Journal: International journal of molecular sciences
Published: March 23, 2026
Sustained Response to Lorlatinib and Pemetrexed in ALK Fusion-Positive Anaplastic Thyroid Carcinoma With Multiple Distant Metastases: A Case Report.
Journal: JCO precision oncology
Published: February 19, 2026
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions.
Journal: JCO precision oncology
Published: December 22, 2025
Clinical Activity of RET TKI Plus Chemotherapy After Progression on a RET TKI in a RET Fusion-Positive NSCLC Real-World Cohort: A Brief Report.
Journal: JTO clinical and research reports
Published: July 23, 2025
Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multicenter Retrospective Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 13, 2025
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Journal: Nature
Published: February 27, 2025
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve EGFR-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 08, 2024
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer.
Journal: Journal for immunotherapy of cancer
Published: September 21, 2024
Author Correction: Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.
Journal: Nature medicine
Published: August 20, 2024
The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer.
Journal: The Annals of thoracic surgery
Published: August 08, 2024
Longitudinal Tracking of ALK-Rearranged NSCLC From Plasma Using Circulating Tumor RNA and Circulating Tumor DNA.
Journal: JTO clinical and research reports
Published: July 11, 2024
Last Updated: 09/26/2026